CHARLES RIVER LABORATORIES's ticker is and the CUSIP is 011376487.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $599,000 | -42.2% | 1,619 | -54.8% | 1.81% | -24.9% |
| Q1 2021 | $1,037,000 | -71.9% | 3,579 | -75.8% | 2.41% | -41.8% |
| Q4 2020 | $3,694,000 | +9.1% | 14,782 | -1.1% | 4.14% | +63.1% |
| Q3 2020 | $3,385,000 | -31.9% | 14,947 | -47.6% | 2.54% | -20.4% |
| Q2 2020 | $4,971,000 | -0.7% | 28,512 | -28.1% | 3.20% | -16.8% |
| Q1 2020 | $5,004,000 | -10.8% | 39,652 | +8.0% | 3.84% | +53.1% |
| Q4 2019 | $5,608,000 | +15.0% | 36,715 | -0.3% | 2.51% | -21.7% |
| Q3 2019 | $4,876,000 | -40.0% | 36,835 | -35.7% | 3.20% | -19.5% |
| Q2 2019 | $8,126,000 | -7.5% | 57,265 | -5.3% | 3.98% | -18.9% |
| Q1 2019 | $8,785,000 | +7.5% | 60,480 | -16.2% | 4.91% | -8.4% |
| Q4 2018 | $8,170,000 | -16.2% | 72,189 | -0.3% | 5.36% | +14.0% |
| Q3 2018 | $9,746,000 | +24.4% | 72,439 | +3.8% | 4.70% | +16.0% |
| Q2 2018 | $7,832,000 | +4.9% | 69,767 | -0.2% | 4.05% | +5.4% |
| Q1 2018 | $7,464,000 | -26.6% | 69,927 | -24.8% | 3.84% | -8.6% |
| Q4 2017 | $10,173,000 | +6.8% | 92,942 | +5.4% | 4.21% | +13.4% |
| Q3 2017 | $9,524,000 | +5.4% | 88,172 | -1.3% | 3.71% | +2.9% |
| Q2 2017 | $9,033,000 | -12.4% | 89,302 | -22.1% | 3.60% | +27.1% |
| Q1 2017 | $10,315,000 | +11235.2% | 114,677 | +9536.7% | 2.84% | +10807.7% |
| Q4 2016 | $91,000 | -8.1% | 1,190 | 0.0% | 0.03% | +18.2% |
| Q3 2016 | $99,000 | – | 1,190 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|